Which treatment is right for you?
Stem cell and exosome therapy is a serious option for chronic discogenic pain and early degeneration. It is not a substitute for surgery when there is clear nerve compression or instability.
Stem cell therapy is the better answer when:
- Chronic discogenic back pain without neuro deficit
- Early-to-moderate disc degeneration
- Failed conservative management at the non-surgical end
- Patients wanting to avoid fusion
Spine Surgery (Discectomy / Fusion / Disc Replacement) is the better answer when:
- Significant motor weakness
- Cauda equina or severe radiculopathy
- Spinal instability
- Failure of regenerative and conservative care
What each option actually is
Wharton's Jelly stem cell therapy
Intradiscal MSC injection (image-guided) and systemic IV infusion are paired with exosomes for anti-inflammatory and pro-regenerative effect on the disc and surrounding facet joints.
Spine Surgery (Discectomy / Fusion / Disc Replacement)
Surgical options include microdiscectomy (relieve nerve), spinal fusion (eliminate motion at the painful segment), and artificial disc replacement (preserve motion). All are major operations with long recovery and finite reversibility.
Side-by-side comparison
| Dimension | Stem cell therapy | Spine Surgery |
|---|---|---|
| Best for nerve compression with deficit | No | Yes |
| Best for chronic discogenic pain | Strong candidate | High failure rate (failed back syndrome) |
| Preserves motion segment | Yes | Fusion eliminates motion |
| Reversibility | Fully reversible | Permanent |
| Recovery time | Weeks | 3–12 months |
| Adjacent-segment disease risk | N/A | Elevated after fusion |
| Cost | €7.5–13.5k | $30k–$120k US |
What patients actually pay
Stem cell therapy: €7,500–€13,500 program.
Spine Surgery: $30,000–$120,000 (lumbar fusion in US private).
Realistic downtime
Stem cell therapy: 1–3 days light activity, 6–8 week graded loading.
Spine Surgery: Fusion: 3–6 months minimum; full return often 9–12 months.
What the published evidence actually says
Published trials of intradiscal MSC therapy (Noriega 2017, Centeno 2017) show pain and function improvement in selected discogenic pain patients. We screen every spine candidate with MRI and a spine surgeon; we will refer for surgery when imaging and exam dictate it.
Common questions when comparing these treatments
Can stem cell therapy fix a herniated disc?
If there is no significant nerve compression or motor deficit, intradiscal MSC therapy can reduce inflammation and support disc hydration in selected patients. If you have foot drop or saddle anesthesia, surgery is the answer.
Is it safer than fusion?
It carries far fewer procedural risks, no instrumentation, and no adjacent-segment disease. It is also not equivalent to fusion in patients who actually need fusion — the goal is to identify the right candidate.
Do you screen with MRI?
Always. Every spine candidate is reviewed by our medical team and a spine surgeon before we accept them for regenerative care.